actON QbD | Episode 3: Not all risks are born equal

In clinical trials, some risks carry more weight than others. Understanding which risks pose the greatest threat is essential for effective risk management and patient safety. But how do you determine which risks deserve the most attention? Should you focus deeply on trial processes, or can that become a distraction? What role does risk detectability play in evaluating the severity of risks?

This episode of actON QbD tackles these vital questions, offering clear guidance on how to prioritize risks through thoughtful evaluation.

What You Will Learn:

• Distinguishing high-impact risks from lower-priority ones
  Learn to identify risks that truly influence study outcomes and patient safety.

• The importance of trial process knowledge
  Discover how understanding protocol details affects risk evaluation without losing sight of the bigger picture.

• Why detectability matters
  Understand how the ability to detect a risk early can change your approach to mitigation and monitoring.

• Applying risk evaluation in practice
  See how Cyntegrity’s MyRBQM® Portal supports comprehensive risk assessment, documentation, and follow-up.

Who Should Attend:

• Clinical Project Managers

• Risk and Quality Managers

• Data Managers

• Regulatory and Compliance Officers

• Anyone involved in Risk-Based Quality Management (RBQM) or Quality by Design (QbD) initiatives

Why This Episode Matters:

Not all risks carry the same consequences, and managing them effectively means focusing resources where they matter most. This session helps clinical teams sharpen their risk evaluation skills and make smarter decisions leading to safer, more reliable trials.

Don’t Miss It!

Join us for practical insights and tools to refine your risk evaluation process. Whether new to RBQM or looking to enhance your current practices, this episode is essential.